UK-based biotech Synthace has secured £1.3m ($2.09m) in seed backing in a round led by venture firm Sofinnova Partner’s Green Seed Fund and joined by angel investors. The University College London (UCL) spin-out, founded in 2011, is developing a platform of technologies aimed at the rapid engineering and optimisation of biological production systems. Through utilising…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
